A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a ...

Measles cases are rising in the U.S., and for many parents, it’s a never-before-seen disease. Here's how to spot the rash, and protect your family against this dangerous infection.

HEFEI, China, 15th January, 2026 (WAM) -- An international research team has uncovered a critical link between common viral infections and multiple sclerosis (MS), offering new insights into the ...

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

Libevitug works by blocking hepatitis B and D viruses from entering liver cells, targeting the PreS1 domain of the viral ...

For a long time, treatments for autoimmune diseases could only quash the symptoms - now new drugs may tackle the underlying ...

Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its ...

Awareness also plays a part. Scientists make key breakthrough in fight against dangerous 'breakbone fever': 'Closer than ever ...

Papzimeos, an HPV-specific immunotherapy, is the first FDA-approved treatment for recurrent respiratory papillomatosis, ...

Deep tooth infections can quietly fuel inflammation that disrupts blood sugar control, and treating them may benefit overall metabolic health.

Regulators granted market authorisation for libevitug as the country's inaugural therapy specifically targeting hepatitis D ...

Huahui Health announced that China's National Medical Products Administration (NMPA) has granted conditional approval to its ...